| Lori Frost Shah, MD | |
|
855 A Ave Ne, Cedar Rapids, IA 52402-5057 | |
| (319) 369-7091 | |
| (319) 369-7071 |
| Full Name | Lori Frost Shah |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 855 A Ave Ne, Cedar Rapids, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912102880 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 29007 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lori Frost Shah, MD 855 A Ave Ne, Cedar Rapids, IA 52402-5057 Ph: (319) 369-7091 | Lori Frost Shah, MD 855 A Ave Ne, Cedar Rapids, IA 52402-5057 Ph: (319) 369-7091 |
News Archive
Leukemia researchers at Princess Margaret Cancer Centre have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment.
An insulin pill being developed by researchers at UC Santa Barbara may in the near future give another blood sugar management option to those who suffer from diabetes. The novel drug delivery technology may also apply to a wide spectrum of other therapies.
New survey findings released by the International Osteoporosis Foundation (IOF) for World Osteoporosis Day show that on average, 93 percent of nearly 1,200 adults surveyed are unaware how common osteoporotic fractures are in men.
NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, today announced that on September 15, 2009 it received notice from the Nasdaq Stock Market that it no longer complies with Nasdaq Marketplace Rule 5550(a)(2) because, for the previous 30 consecutive business days, the bid price of its common stock had closed below the minimum requirement of $1.00 per share.
Navigant announced today that it has acquired EthosPartners Healthcare Management Group, Inc., a national healthcare consulting group specializing in physician and hospital alignment, physician practice operations management, and physician revenue cycle management. Combining EthosPartners' physician expertise with Navigant's existing healthcare practice capabilities significantly enhances and broadens the solutions that Navigant offers to its clients.
› Verified 9 days ago
Chirantan Ghosh, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1951 51st St Ne, Cedar Rapids, IA 52402 Phone: 319-294-1899 Fax: 319-294-1773 | |
Leon L Qiao, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 931 8th Ave Se, Cedar Rapids, IA 52401 Phone: 319-366-8695 Fax: 319-366-0795 | |
Boothapuri Venkatesh, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 202 10th St Se, Suite 225, Cedar Rapids, IA 52403 Phone: 319-364-7101 Fax: 319-363-1993 | |
Harinder Singh, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 202 10th St Se, Cedar Rapids, IA 52403 Phone: 319-398-1546 | |
Hisham Wagdy, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 202 10th St Se, Suite 225, Cedar Rapids, IA 52403 Phone: 319-364-7101 Fax: 319-363-1993 | |
Deborah W Wilbur, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 701 10th St Se, Hpcc 3rd Floor, Cedar Rapids, IA 52403 Phone: 319-363-8303 Fax: 319-364-4659 | |
Dr. Wei Li, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 543 7th St Se, Cedar Rapids, IA 52401 Phone: 319-861-7600 |